AR and cancer: Currently, clinical trials are underway investigating therapeutic strategies for combining AR blockade with chemotherapy, targeted therapy, or immune checkpoint blockade in patients with advanced cancers (NCT04926181, NCT01974765, NCT03207529, NCT02684227, NCT02312557).